GENEVA: TANZANIA has submitted a proposed resolution on “Smart Pharmacovigilance,” which aims to strengthen drug safety monitoring, recognizing that a large proportion of deaths resulting from adverse drug reactions occur in developing countries.
Tanzania made the statement in Geneva during the 158th Executive Board Meeting of the World Health Organization (WHO), taking place in Switzerland, from February 2 to 7, 2026.
The meeting serves as part of the preparations for the 79th World Health Assembly scheduled for May 2026.
During the meeting, Tanzania has presented and discussed various strategies aimed at strengthening health systems, including preparedness and response to health emergencies, non-communicable diseases, mental health, immunization implementation, the fight against tuberculosis, neglected diseases, universal health coverage, primary healthcare, and efforts to combat antimicrobial resistance.
ALSO READ: Strengthen medicine safety, Pharmacists told
The Tanzanian delegation is led by the Chief Medical Officer, Dr Grace Magembe, in collaboration with Tanzania’s Ambassador and Permanent Representative to the United Nations in Geneva, Ambassador Dr. Abdallah Saleh Possi, together with health experts from the Ministry of Health and the Tanzania Embassy in Geneva.
Alongside the meeting, the Chief Medical Officer, Dr Grace Magembe, is expected to hold bilateral meetings with key partners, including the Global Fund and UNITAID, to discuss strengthening collaboration, financing programs for malaria, tuberculosis and HIV/AIDS, as well as promoting local production of health products.